Stevens-Johnson Syndrome

Stevens-Johnson Syndrome: Symptoms, Causes, Types, Diagnosis, and Treatments

Stevens-Johnson Syndrome (SJS) is a rare but serious disorder of the skin and mucous membranes, often considered a medical emergency. It typically begins with flu-like symptoms, followed by a painful red or purplish rash that spreads and blisters, eventually causing the top layer of skin to die and shed. Though SJS can affect people of all ages, it is most commonly seen in adults and is more severe in older individuals.

Understanding Stevens-Johnson Syndrome in depth is crucial because early diagnosis and prompt treatment can significantly improve outcomes. This article will walk you through everything you need to know about SJS—its symptoms, causes, types, diagnosis, and treatment—so you can be better informed or help someone in need.

What is Stevens-Johnson Syndrome?

Stevens-Johnson Syndrome is a hypersensitivity complex that affects the skin and mucous membranes. It is typically a reaction to medications, infections, or, in rare cases, vaccines. SJS falls under the category of severe cutaneous adverse reactions (SCARs) and can progress to a more dangerous condition called Toxic Epidermal Necrolysis (TEN) if more than 30% of the body surface area is affected.

SJS involves the detachment of the epidermis (outer skin layer) from the dermis, leading to raw, painful areas on the skin and mucous membranes (such as the eyes, mouth, and genitals). In extreme cases, it may lead to long-term complications or even death if not treated promptly.

Symptoms of Stevens-Johnson Syndrome

Recognizing the symptoms of Stevens-Johnson Syndrome early can be life-saving. The condition usually starts with nonspecific flu-like symptoms before progressing to more severe skin and mucosal manifestations.

Early Symptoms (1 to 3 days before the rash):

  • Fever
  • Fatigue
  • Sore throat
  • Cough
  • Burning eyes
  • Body aches

Skin and Mucosal Symptoms:

  • Painful red or purplish rash that spreads
  • Blistering on the skin and mucous membranes
  • Shedding of the skin
  • Swelling of the face and tongue
  • Crusting of the eyes, mouth, and genital areas
  • Sensitivity to light (photophobia)
  • Difficulty swallowing or urinating

Late or Severe Symptoms:

  • Large areas of skin detachment
  • Respiratory distress
  • Secondary infections (sepsis)
  • Organ damage (lungs, liver, kidneys)

Causes of Stevens-Johnson Syndrome

SJS is most often triggered by medications or infections, although genetic and environmental factors may also play a role.

Medications (Most Common Cause):

Up to 80% of SJS cases are associated with drug reactions. The most common medications include:

  • Antibiotics: Sulfonamides (e.g., sulfamethoxazole), penicillins
  • Anti-epileptics: Phenytoin, carbamazepine, lamotrigine
  • NSAIDs: Especially oxicams (piroxicam)
  • Allopurinol: Used for gout
  • Antifungal agents: Rarely implicated

Infections:

SJS may also be caused by infections, particularly in children. Common infectious triggers include:

  • Herpes Simplex Virus (HSV)
  • Mycoplasma pneumoniae
  • HIV/AIDS
  • Hepatitis
  • Epstein-Barr Virus (EBV)

Other Causes:

  • Vaccinations: Rarely linked to SJS in children
  • Malignancies: Especially lymphomas and leukemia
  • Radiation therapy
  • Genetics: Certain HLA types (e.g., HLA-B*1502) increase susceptibility

Types of Stevens-Johnson Syndrome

SJS is typically considered a spectrum of disease severity along with Toxic Epidermal Necrolysis. These conditions are classified based on the percentage of body surface area (BSA) affected.

Stevens-Johnson Syndrome (SJS):

  • Involves less than 10% of BSA
  • Milder but still life-threatening
  • Mainly affects mucous membranes and skin

Toxic Epidermal Necrolysis (TEN):

  • Involves more than 30% of BSA
  • More extensive skin detachment
  • High risk of complications and mortality

SJS/TEN Overlap:

  • Affects between 10% to 30% of BSA
  • Features of both SJS and TEN

Who is at Risk?

SJS can affect anyone, but certain factors increase the risk:

  • Age: More common and severe in adults
  • Gender: Slightly more common in females
  • Genetics: HLA-B*1502 gene in Southeast Asians
  • HIV Infection: 100 times more likely than in the general population
  • Weakened Immune System: Cancer, organ transplant recipients
  • Previous SJS Episode: High risk of recurrence

Diagnosis of Stevens-Johnson Syndrome

Prompt and accurate diagnosis is essential for effective management. Diagnosing SJS is largely clinical, supported by laboratory and histopathological findings.

Clinical Evaluation:

  • Thorough medical history (drug intake, infection, prior illnesses)
  • Physical examination of skin, mucosa, eyes, and genitals
  • Check body surface area involvement

Laboratory Tests:

  • CBC: May show leukopenia or anemia
  • Liver/Kidney function tests: To detect organ involvement
  • Cultures: Blood, urine, or wound cultures if infection is suspected

Skin Biopsy:

  • Confirms diagnosis
  • Shows necrotic keratinocytes and full-thickness epidermal necrosis

Imaging and Other Tests:

  • Chest X-ray: If respiratory symptoms are present
  • Eye examination: To assess conjunctival damage
  • Urinalysis: For signs of kidney involvement

Treatment of Stevens-Johnson Syndrome

The cornerstone of SJS management is immediate withdrawal of the causative agent and supportive care. In severe cases, hospitalization in a burn unit or intensive care unit (ICU) is essential.

Discontinuation of the Offending Drug:

  • First and most crucial step
  • Should be done as soon as SJS is suspected

Hospitalization and Supportive Care:

  • Fluid and electrolyte management
  • Temperature regulation
  • Nutritional support (may need feeding tubes)
  • Pain management
  • Infection prevention (sterile environment, antibiotics if needed)
  • Wound care (non-adhesive dressings, antiseptics)

Medications:

  • Corticosteroids: Controversial but may reduce inflammation if started early
  • Intravenous Immunoglobulins (IVIG): Blocks Fas-mediated keratinocyte apoptosis
  • Cyclosporine: Immunosuppressant showing promise in SJS/TEN
  • Etanercept and TNF-alpha inhibitors: In some cases

Ophthalmic and Mucosal Care:

  • Frequent eye examinations
  • Lubricating eye drops
  • Antibiotic eye ointments if infection is suspected
  • Oral rinses for mucosal healing

Skin Grafting and Surgical Intervention:

  • Required in extensive TEN
  • Plastic surgery consultations for skin coverage

Recovery and Prognosis

The course of SJS varies depending on the severity and treatment timeliness. Recovery may take weeks to months. The mortality rate for SJS is about 5-10%, while TEN has a mortality rate up to 30%.

Long-term Complications:

  • Ocular issues: Dry eyes, vision loss, conjunctival scarring
  • Skin changes: Pigmentation abnormalities, scarring
  • Nail loss or deformity
  • Mucosal strictures: Oral, genital, esophageal
  • Psychological impact: PTSD, anxiety

Prevention of Stevens-Johnson Syndrome

While SJS cannot always be prevented, certain measures can help reduce the risk:

Genetic Screening:

  • Individuals of Asian descent should be screened for HLA-B*1502 before taking carbamazepine or phenytoin

Medication Caution:

  • Avoid known triggers
  • Inform all healthcare providers about any drug allergies or previous SJS episodes

Informed Prescription:

  • Physicians should avoid polypharmacy when possible
  • Use alternative medications in high-risk individuals

Education:

  • Patients should be educated to seek immediate medical attention if flu-like symptoms or rash occurs after starting a new drug

Stevens-Johnson Syndrome in Children

In children, infections are more often the cause of SJS than medications. Mycoplasma pneumoniae is a common trigger. Treatment principles remain the same, but pediatric patients need more specialized care and emotional support.

SJS vs Other Conditions

SJS must be differentiated from other similar skin conditions:

  • Erythema multiforme (EM): Milder, usually self-limiting
  • Bullous pemphigoid and pemphigus vulgaris
  • Staphylococcal Scalded Skin Syndrome (SSSS): Affects infants and young children
  • Drug rash with eosinophilia and systemic symptoms (DRESS): Features systemic involvement

When to Seek Emergency Help

You should seek immediate emergency care if you or someone else experiences:

  • Rapid spread of rash or blisters
  • Painful sores in the mouth, eyes, or genitals
  • High fever with rash
  • Peeling skin
  • Difficulty breathing or swallowing

Living with the Aftermath of SJS

Survivors often face physical, emotional, and psychological challenges. Follow-up care with dermatologists, ophthalmologists, and mental health professionals is essential. Joining support groups and communities can help in coping with post-SJS life.

Conclusion

Stevens-Johnson Syndrome is a medical emergency that demands prompt recognition and treatment. Although rare, its potential to cause life-threatening complications makes awareness critical. Whether it arises from medications or infections, early discontinuation of the trigger and intensive supportive care are vital for survival and recovery.

Understanding the causes, symptoms, and treatments of SJS not only empowers individuals but also helps healthcare providers make quicker decisions. If you suspect SJS in yourself or someone else, do not wait—seek immediate medical attention.

Frequently Asked Questions (FAQs) About Stevens-Johnson Syndrome

What is Stevens-Johnson Syndrome (SJS)?

Stevens-Johnson Syndrome is a rare, serious disorder of the skin and mucous membranes, usually triggered by a reaction to medications or infections. It causes the skin to blister, peel, and slough off, often requiring emergency medical care.

What are the early warning signs of SJS?

Initial symptoms often resemble the flu—fever, sore throat, fatigue, and body aches. These are followed by painful red or purplish rashes that spread and form blisters, especially around the mouth, eyes, and genitals.

What causes Stevens-Johnson Syndrome?

The most common cause is an adverse reaction to medications such as antibiotics (e.g., sulfa drugs), anticonvulsants, and NSAIDs. Infections like herpes simplex, pneumonia, or hepatitis may also trigger the condition.

How serious is Stevens-Johnson Syndrome?

SJS is a life-threatening condition that can lead to severe complications such as skin infections, vision loss, organ damage, or even death if not treated promptly.

Is Stevens-Johnson Syndrome contagious?

No, SJS is not contagious. It is an immune-mediated response, usually to medication or infection, and cannot be transmitted from person to person.

Who is at risk of developing SJS?

People with weakened immune systems, those with a personal or family history of drug allergies, and individuals taking specific high-risk medications are more likely to develop SJS.

How is Stevens-Johnson Syndrome diagnosed?

Doctors typically diagnose SJS through clinical examination, medical history review, and sometimes a skin biopsy. Blood tests may also be used to detect infections or immune system activity.

What are the treatment options for SJS?

Treatment includes immediate discontinuation of the offending drug, hospitalization (often in a burn unit), wound care, intravenous fluids, pain management, and sometimes corticosteroids or immunoglobulin therapy.

How long does it take to recover from Stevens-Johnson Syndrome?

Recovery can take weeks to months, depending on severity. Some patients may heal completely, while others may experience lasting complications like skin scarring, vision problems, or organ damage.

Can Stevens-Johnson Syndrome come back?

Yes, recurrence is possible if the patient is re-exposed to the triggering medication or substance. Patients must avoid known triggers and wear medical alert identification.

What is the difference between SJS and toxic epidermal necrolysis (TEN)?

Both are part of the same disease spectrum. SJS affects less than 10% of the body surface area, while TEN involves more than 30%. TEN is more severe and has a higher mortality rate.

Can children get Stevens-Johnson Syndrome?

Yes, children can develop SJS, often due to infections rather than medications. Pediatric cases require immediate hospital care and monitoring.

Is there a genetic link to SJS?

Yes, certain genetic markers (e.g., HLA-B*1502 in Asians) are linked to higher risks of developing SJS in response to specific drugs, like carbamazepine.

How can Stevens-Johnson Syndrome be prevented?

Prevention involves avoiding known trigger medications, informing healthcare providers of drug allergies, and undergoing genetic screening when recommended.

Is there a cure for Stevens-Johnson Syndrome?

There is no specific cure, but with prompt and appropriate treatment, many patients recover. Management focuses on symptom relief, preventing complications, and identifying the trigger.

For more details keep visiting our Website & Facebook Page.

© 2025 Health DMS. All Rights Reserved.

Home
about Us
Contact Us